GlaxoSmithKline Pharma wins AmCham award  

GSK gains recognition for its research, competitiveness and corporate citizenship in Denmark
GlaxoSmithKline Pharma A/S (GSK) has won the 2008 Foreign Company of the Year Award from the American Chamber of Commerce (AmCham) in Denmark.
“We are honoured to accept this award from the American Chamber of Commerce," said GSK Managing Director Julie Edwards in an AmCham press release. "GSK invests significantly in research in universities and hospitals in Denmark, and looks forward to a continued, strong local engagement," she added.
The annual AmCham award highlights the significance of FDI in Denmark and recognizes the contributions made by foreign companies operating in this country.
The award’s jury panel, consisting of Toms Gruppen CEO Jesper Møller, Director Henning Dyremose, and Copenhagen Business School Professor Steen Thomsen, cited GSK’s significant investment in research and development in Denmark, its beneficial impact on Denmark’s international competitiveness, and its contributions to Danish society in the form of employee education and development.
Previous winners of AmCham’s Foreign Company of the Year Award include iMotions and Topsoe Fuel Cell.
AmCham Denmark represents more than 290 companies actively investing in Denmark, advocating for the best possible environment for investment in Denmark, and to remove barriers to transatlantic trade.

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×